Loading news article.

FilingSEC EDGAR8-K

Valion Bio Issues Series B Preferred Shares and Warrants for $50,000

Oct 8, 2026, 06:00 ET · SEC accepted

StageAgreement Signed

Filing content

Valion Bio entered into an agreement with 3i, LP to issue 50 Series B Preferred Shares and warrants to purchase common stock for an aggregate purchase price of $50,000.

AI summary of the filing. Please also check the source.

Related companies

Valion Bio, Inc.VBIOView stock

Analyzed by WAPE AI.

Preparing English content…

Repost

Comments —

Loading comments…